Transcription factor NF-E2 is required for platelet formation independent of the actions of thrombopoeitin/MGDF in megakaryocyte development  by Shivdasani, Ramesh A et al.
Cell, Vol. 81,695-704, June 2, 1995, Copyright © 1995 by Cell Press 
Transcription Factor NF-E2 Is Required for Platelet 
Formation Independent of the Actions of Thrombopoietin/ 
MGDF in Megakaryocyte Development 
Ramesh A. Shivdasani,*t Margery F. Rosenblatt,t 
Dorothea Zucker-Franklin,$ Carl W. Jackson,§ 
Pamela Hunt, II Chris J. M. Saris, II 
and Stuart H. Orkint# 
*Division of Medical Oncology 
Dana-Farber Cancer Institute 
and Department of Medicine 
Harvard Medical School 
#Howard Hughes Medical Institute 
tDivision of Hematology-Oncology 
The Children's Hospital 
and the Dana-Farber Cancer Institute 
and Department of Pediatrics 
Harvard Medical School 
Boston, Massachusetts 02115 
SDepartment of Medicine 
New York University Medical Center 
New York, New York 10016 
§Division of Experimental Hematology 
St. Jude Children's Research Hospital 
Memphis, Tennessee 38105 
IIAmgen, Incorporated 
Amgen Center 
Thousand Oaks, California 91320 
Summary 
Despite the importance of blood platelets in health and 
disease, the mechanisms regulating their formation 
within megakaryocytes are unknown. We generated 
mice lacking the hematopoietic subunit (p45) of the 
heterodimeric erythroid transcription factor NF-E2. 
Unexpectedly, NF-E2 -I- mice lack circulating platelets 
and die of hemorrhage; their megakaryocytes show 
no cytoplasmic platelet formation. Though platelets 
are absent, serum levels of the growth factor thrombo- 
poietin/MGDF are not elevated above controls. None- 
theless, NF-E2 -/- megakaryocytes proliferate in vivo in 
response to thrombopoietin administration. Thus, as 
an essential factor for megakaryocyte maturation and 
platelet production, NF-E2 must regulate critical target 
genes independent of the action of thrombopoietin. 
These findings provide insight into the genetic analy- 
sis of megakaryocyte maturation and thrombopoiesis. 
Introduction 
Circulating blood platelets constitute a primary defense 
against bleeding and are essential for survival (Lind, 
1995). Abnormalities in platelet number or function con- 
tribute to various hemorrhagic and thrombotic disorders, 
and the events surrounding platelet activation have been 
studied extensively. In contrast, megakaryocytes, the pre- 
cursors of platelets, have been less well characterized, in 
part because they constitute less than 1% of the cellular 
elements in normal bone marrow. 
Like other blood cells, megakaryocytes differentiate 
from pluripotent hematopoietic stem cells in a process that 
imparts a unique phenotype to each lineage, including 
the expression of characteristic gene products and the 
response to specific growth factors. The distinctive pat- 
terns of gene expression of individual ineages are estab- 
lished largely through the aegis of cell-specific transcrip- 
tion factors, several of which have been implicated in the 
determination of hematopoietic ell fate and maturation. 
For example, the nuclear proteins GATA-1 (Pevny et al., 
1991), Myb (Mucenski et al., 1991), Rbtn2 (Warren et al., 
1994), TaI-1/SCL (Shivdasani et al., 1995), Ikaros (Georg- 
opoulos et al., 1994), E2A (Bain et al., 1994; Zhuang et 
al., 1994), Pax5/BSAP (Urbdnek et al., 1994), and PU.1 
(Scott et al., 1994) are essential for normal erythroid, 
lymphoid, or myeloid differentiation. The transcriptional 
basis of megakaryocyte development remains undefined. 
The megakaryocytic and erythroid lineages are closely 
related in ontogeny: both cell types are derived from a 
common committed progenitor (Suda et al., 1983; Ogawa, 
1989). Moreover, the proliferation and maturation of mega- 
karyocyte and erythroid precursors are regulated by struc- 
turally related growth factors, thrombopoietin (also called 
megakaryocyte growth and development factor, or MGDF) 
and erythropoietin, respectively (reviewed by Metcalf, 
1994). Further, important ranscription factors, including 
GATA-1 (Martin et al., 1990; Romeo et al., 1990), NF-E2 
(Andrews et al., 1993a), and TaI-1/SCL (Mouthon et al., 
1993), are coexpressed within the two lineages, raising 
the possibility of common programs or mechanisms of 
gene activation. 
Megakaryocyte maturation and platelet production are 
complex processes. Early in their development, mega- 
karyoblasts undergo successive rounds of DNA replica- 
tion without cell division (endomitosis), resulting in poly- 
ploidy (Odell and Jackson, 1968). Cytoplasmic maturation 
is characterized by the formation of granules containing 
procoagulant substances and the development of an ex- 
tensive system of demarcation membranes, which delimit 
platelet territories, or platelet fields. Individual platelets 
are released upon fragmentation of the megakaryocyte 
cytoplasm (Zucker-Franklin and Petursson, 1984) or after 
formation of cytoplasmic processes called proplatelets 
(Choi et al., 1995). 
The recent discovery that thrombopoietin/MGDF acts 
through the megakaryocyte-specific receptor c-Mpl (Souyri 
et al., 1990) to promote proliferation and maturation of 
megakaryocyte precursors has provided impetus for the 
study of megakaryocyte biology (Bartley et al., 1994; de 
Sauvage et al., 1994; Kaushansky et al., 1994; Lok et al., 
1994; Wendling et al., 1994). However, the mechanisms 
responsible for the activities attributed to this factor remain 
to be explored. Notably, although mpl-knockout mice are 
thrombocytopenic, they do not suffer a bleeding diathesis 
(Gurney et al., 1994). Hence, additional growth factors 
act in vivo to promote megakaryocyte development and 
platelet production. 
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We have studied the transcription factor NF-E2, a pro- 
tein first shown to bind tandem AP-l-like motifs within 
DNase I hypersensitive site 2 of the locus control region 
(LCR) of the human 13-globin gene cluster (Mignotte et 
al., 1989; Ney et al., 1990a; Talbot et al., 1990). As the 
sequences to which it binds are critical for LCR activity 
in transgenic mouse and cell transfection assays (Ney et 
al., 1990b; Talbot and Grosveld, 1991; Caterina et al., 
1994), a role for N F-E2 in eryth roid cell globin gene expres- 
sion has been inferred. NF-E2 is an obligate heterodimer 
of hematopoietic-restricted 45 kDa (p45) and widely ex- 
pressed 18 kDa (p18) subunits, which belong to the CNC 
and Maf subfamilies, respectively, of the basic region- 
leucine zipper (bZIP) superfamily of nuclear proteins (An- 
drews et al., 1993a, 1993b; Igarashi et al., 1994). The p45 
subunit is coexpressed with GATA-1 in hematopoietic ells 
of erythroid, megakaryocyte, and mast cell lineages (An- 
drews et al., 1993a). While NF-E2 has been implicated as 
the major enhancer for globin gene expression in maturing 
erythroid cells, its function elsewhere is unknown. 
To define the in vivo roles of NF-E2, we used gene tar- 
geting in embryonic stem (ES) cells (Capecchi, 1989) to 
generate mice lacking the p45 subunit. Although we antici- 
pated that these mice would die early in development be- 
cause of inadequate hemoglobin production, this was not 
the case; erythropoiesis was relatively normal. Instead, 
mice lacking p45 NF-E2 exhibited high mortality from hem- 
orrhage secondary to the absence of circulating platelets 
(absolute thrombocytopenia). Megakaryocytes were pres- 
ent, and ultrastructural studies revealed the failure of 
platelet formation within their cytoplasm. Despite this 
block in cellular maturation, the proliferative response of 
mutant megakaryocytes to thrombopoietin was intact. 
Our findings indicate that NF-E2 regulates the expres- 
sion of one or more target genes required for the comple- 
tion of megakaryocyte maturation and platelet production. 
Together with emerging studies on thrombopoietin-medi- 
ated signaling through Mpl, these findings provide a frame- 
work for molecular genetic approaches to the study of 
platelet production. 
Results 
Targeted Disruption of the Murine p45 NF-E2 Gene 
The murine p45 NF-E2 gene contains three xons, the 
last of which encodes the bZIP region required for DNA 
binding and protein dimerization (Andrews et al., 1993a). 
To inactivate the gene, a targeting construct was assem- 
bled in which a neo R cassette was inserted in exon 3, imme- 
diately upstream of sequences encoding the basic domain 
(Figure 1A). Any product translated from the disrupted al- 
lele would thus be unable to bind DNA or form heterodim- 
ers and consequently would be inactive. 
Following electroporation of the targeting construct, ES 
cell clones were selected in G418 and assayed by South- 
ern blot analysis (Figure 1B), which revealed homologous 
recombination in -40% of G418-resistant clones. Two 
independent clones contributed to the germline of chime- 
ric mice, whose heterozygous (p45 NF-E2 +1-) offspring 
were interbred to generate homozygotes. Mutant mouse 
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Figure 1. Targeted Disruption of the Mouse p45 NF-E2 Gene 
(A) Partial restriction map of the mouse p45 NF-E2 locus with the 
targeting construct depicted below. Exons 1-3 are shown as boxes, 
with the sequences encoding the bZlP region hatched. Homologous 
recombination resulted in insertion of a PGK-neo cassette (Neo R) in 
antisense orientation into he unique Sail site upstream of the bZlP 
region. The wild-type and targeted alleles could be distinguished by 
Southern blot analysis using the indicated 5' flanking probe. Hd,
Hindlll; RV, EcoRV; Sal, SaU; <N>, artificial Notl site. 
(B) Southern blot analysis of G418-resistant ES cell clones. Targeted 
clones (asterisks) are distinguished from nonhomologous recombi- 
nants by the presence of both wild-type (5 kb) and disrupted (7 kb) 
alleles. 
(C) Southern blot analysis of progeny from a p45 NF-E2 + intercross, 
indicating the presence of all expected genotypes, including homozy- 
gous mutants (asterisk). 
stocks were maintained on either a mixed 129/Sv-C57BL/6 
or inbred 129/Sv background; no difference was observed 
between these lines or between mice derived from the two 
ES cell clones. 
p45 NF-E2 ÷j- mice appeared normal up to 1 year of age, 
and interbreeding yielded p45 NF-E2 + mice at the ex- 
pected Mendelian frequency of 1 in 4 (Figure 1C). Absence 
of intact p45 NF-E2 mRNA and protein in fetal liver sam- 
ples of homozygotes was demonstrated by Northern blot 
and immunoblot analyses, respectively (Figures 2A and 
2C). Although a readthrough transcript containing the in- 
serted neo phosphotransferase gene sequences was de- 
tected in fetal liver RNAs of (+/-) as well as ( - / - )  mice 
(Figure 2A), DNA sequencing of the targeting construct 
confirmed that the insertion provided multiple in-frame 
stop codons (data not shown). Thus, the targeting pro- 
duced a null mutation of the p45 NF-E2 gene. 
Adventitious integration of Friend virus DNA in CB3 
erythroleukemia cells inactivates the p45 NF-E2 gene as 
well as the adjacent gene that encodes the heterogeneous 
nuclear RNA-binding protein A1 (hnRNPA1) (Ben-David 
et al., 1992; Lu et al., 1994). Although this is likely due to 
a distance effect exerted by viral long terminal repeats, 
we excluded the possibility that disruption of the p45 NF- 
E2 gene in ES cells also inactivated this linked gene. 
hnRNPA1 mRNA was present at normal levels in p45 NF- 
E2 -/- fetal liver (Figure 2B). The phenotype we describe 
below for homozygous mice thus represents the specific 
consequences of absence of p45 NF-E2. 
Hemorrhage and Perinatal Mortality 
in p45 NF-E2 + Mice 
p45 NF-E2 + mice were distinguished after birth by pallor 
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Figure 2. Targeted Disruption Results in a Null Mutation 
(A) Northern blot analysis of fetal liver RNA from mice of p45 NF-E2 
(+/+), (+/-), and (-/-) genotypes. The positions of migration of 18S 
and 28S species are indicated. The filter was first probed with full- 
length p45 NF-E2 cDNA (left), then stripped and hybridized with a neo 
phosphotransferase (Neo R) probe (right). p45 NF-E2 mRNA, which 
comigrates with the 18S species, is absent in (-/-) m ice. A readth rough 
transcript containing neo R is detected in (+/-) and (-/-) samples. 
(B) The same filter was stripped again and hybridized with a PCR 
fragment corresponding to nucleotides 151-925 of mouse hnRNPA1 
cDNA (Ben-David et al., 1992). 
(C) Immunoblot analysis of fetal liver p otein extracts from mouse ryth- 
roleukemia (MEL) cells and from mice of p45 NF-E2 (+/+), (+/-), and 
(-/-) genotypes, indicating complete absence of the p45 NF-E2 protein 
(arrow) in (-/-) mice. 
and internal hemorrhage occurring primarily into the peri- 
toneal cavity and the wall of the urinary bladder (Figure 
3), presumably as a complication of birth-related trauma. 
Although the frequency of homozygotes at birth was as 
expected ( -  25%), less than 10% of the liveborn homozy- 
gotes survived to adulthood, and surviving neonates were 
smaller than littermates (Figure 3A), presumably as a re- 
sult of sustained hemorrhage during a period of rapid 
growth. With the exception of splenomegaly, which was 
present at birth and persisted thereafter, the appearance 
and histology of other organs were normal. However, hem- 
orrhage was frequently observed in the gastrointestinal 
tract, brain, testes, pericardium, and mouth. Significant 
bleeding was not detected in embryos delivered by cesar- 
ean section. 
Thus, the majority of p45 N F-E2 -~- mice die in the neona- 
tal period as a consequence of hemorrhage. Although ane- 
mia was observed intermittently in surviving adult homozy- 
gotes, these mice appeared otherwise normal. Both sexes 
were fertile. 
Absence of Platelets in p45 NF-E2 -~- Mice 
p45 NF-E2 -/- mice succumb to bleeding due to the ab- 
sence of circulating platelets (absolute thrombocyto- 
penia). In contrast with wild-type and heterozygous lit- 
termates, whose platelet counts were between 5 x 10s/ 
Id (young mice) and 0.8 to 1.4 x 10e/p.I (adults), no plate- 
lets could be identified in blood smears (Figure 4A), or by 
automated analysis of blood (Figure 4B), from p45 NF-E2 + 
mice. Thrombocytopenia was evident during embryonic 
development and persisted throughout life. 
Transfer of serum from p45 NF-E2 + mice failed to lower 
platelet counts in normal recipients either 1-2 hr after intra- 
venous injection or up to 1 week following daily intraperito- 
neal injections (data not shown). Thus, thrombocytopenia 
does not result from platelet destruction by a soluble factor 
but reflects a primary failure in platelet formation. In the 
spleen and bone marrow of mutant mice, megakaryocytes 
were present in slight excess (2- to 4-fold) relative to wild- 
type or heterozygous littermates (Figure 4C). The majority 
of these cells appeared larger than control megakaryo- 
cytes and exhibited hyperlobulation of the nucleus and 
striking emperipolesis (nonphagocytic inclusion of other 
blood cells within the cytoplasm [Breton-Gorius, 1981]). 
Taken together, these findings indicate that thrombocyto- 
penia in p45 NF-E2 + mice occurs despite the presence 
of megakaryocytes and point to a maturation defect as 
the cause for absence of circulating platelets. 
Hematological Analysis of p45 NF-E2 -I- Mice 
The numbers and morphology of granulocytes and lym- 
phocytes in blood and bone marrow were normal in p45 
NF-E2 -/- mice (data not shown). In contrast, mild, but con- 
sistent, changes were seen in the red blood cells. As will be 
described elsewhere, these included reduced hemoglobin 
concentration and microcytosis that cannot be explained 
fully by either blood loss or iron deficiency (R. A. S. et al., 
unpublished data). Hence, the absence of NF-E2 affects 
erythrocytes only mildly, but leads to profound conse- 
quences for megakaryocytes, a second lineage in which 
it is normally expressed. 
Absence of p45 NF-E2 Results in a Late Block 
in Megakaryocyte Maturation 
Normal megakaryocyte development initiates with the pro- 
A B Figure 3. Hemorrhage in p45 NF-E2 =~- Neo- nates 
(A) Appearance of mutant mice (-/-) compared 
with control iittermates I day after birth. Distin- 
guishing features include pallor, slightly 
smaller size, and intraabdominal blood collec- 
tions. 
(13) Transverse section through t e wall of the 
urinary bladder of a 3-day-old p45 NF-E2 -~- 
°mouse, demonstrating extensive submucosal 
hemorrhage. Magnification, 75 x. 
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Figure 4. Absolute Thrombocytopenia in p45 NF-E2 ~ Mice Despite 
the Presence of Megakaryocytes 
(A) Microscopic examination of a peripheral blood smear from a lit- 
termate (age 9 weeks; left) shows abundant platelets (p); in contrast, 
no platelets are detected in the smear from a representative mutant 
mouse (right). Magnification, 250 x.  
(B) Platelet volume histograms obtained by automated analysis of 
blood samples confirm absolute thrombocytopenia in p45 NF-E2 -~- 
(right) mice. 
(C) Transverse sections through the spleens of control (left) and mutant 
(right) mice demonstrate the presence of megakaryocytes (M) in each, 
with abnormal morphology evident in p45 NF-E2 -~- mice. Magnifica- 
tion, 100 x.  
liferation of precursor cells. Later, these cells undergo en- 
domitosis, followed by cytoplasmic maturation and organi- 
zation, which culminate in platelet release (Zucker-Franklin, 
1989). To identify the stage at which NF-E2 is required, 
we examined megakaryocyte-specific mRNA levels by re- 
verse transcription-polymerase chain reaction (RT-PCR). 
mRNAs encoding platelet factor 4 (PF4) and glycoprotein 
lib (GPIIb), early markers of the megakaryocyte lineage 
(Deuel et al., 1977; Beckstead et al., 1986), were ex- 
pressed at similar levels in fetal livers of p45 NF-E2 -~- and 
control mice (Figure 5A). Other early markers of mouse 
megakaryocytes, acetylcholinesterase activity (Jackson, 
1973), and surface expression of the epitope defined by 
the 4A5 monoclonal antibody (Burstein et al., 1992), were 
also detected in mutant megakaryocytes (data not shown). 
Thus, megakaryocyte maturation in p45 NF-E2 -~- mice is 
affected after the stage at which these markers are ex- 
pressed, and NF-E2 is not essential for their expression. 
To determine whether endomitosis was affected by the 
absence of NF-E2, we performed DNA ploidy analysis on 
bone marrow cells. The modal ploidy class of p45 NF-E2 -~- 
megakaryocytes was 32N, compared with 16N in controls 
(Figure 5B), indicating that endomitosis is not impaired in 
the mutant cells. Together, these experiments demon- 
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Figure 5. Normal Aspects of Early Megakaryocyte Maturation in p45 
NF-E2 -~- Mice 
(A) RT-PCR analysis of PF4 and GPIIb mRNAs from the fetal livers 
of mutant (-/-)  and heterozygous (+/-) mice. PCR reactions were 
carried out with tracer [32P]dCTP for the indicated number of cycles, 
and reaction products analyzed by polyacrylamide g l electrophoresis 
as detailed under Experimental Procedures. 
(B) Histograms of the DNA content of megakaryocytes from the bone 
marrow of heterozygous (con; top) and mutant (-/-; bottom) mice, 
indicating that endomitosis has progressed appropriately in both 
cases. 
strate that early phases of megakaryocyte development 
proceed normally in the absence of NF-E2. 
Intrinsic Megakaryocytic Abnormalities Revealed 
by Electron Microscopy 
To characterize the maturation defect further, we per- 
formed electron microscopy of bone marrow cells, In con- 
trast with control megakaryocytes (Figures 6A and 6B), 
which exhibited well-formed platelet territories or fields 
(Zucker-Franklin, 1989), p45 NF-E2 -~- megakaryocytes 
were larger and exhibited a paucity of granules (Figure 
6C). In addition, cytoplasmic territories, the recognized 
precursors of platelets, were not delimited by the demarca- 
tion membranes; instead, the latter lacked appropriate or- 
ganization and appeared to be in disarray (Figure 6D). 
Nuclei of mutant megakaryocytes were hyperlobulated, 
with a peripheral heterochromatin distribution reminiscent 
of blast cells, while some profiles presented numerous 
pinched-off nuclear fragments (data not shown). Similar 
abnormalities were noted in splenic megakaryocytes. 
In summary, ultrastructural analysis of p45 NF-E2 -~- 
NF-E2 in Megakaryocyte Maturation and Thrombopoiesis 
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Figure 6. Ultrastructural Analysis of Megakaryocyte Abnormalities 
(A) Mature megakaryocyte of a control mouse illustrates the normal number and distribution ofgranules. Magnification, 2 800 x. 
(B) Detail of the cytoplasm of the megakaryocyte shown in (A). Platelet fields, or territories (P), are clearly demarcated. A granule (arrow) is seen 
to form at the Golgi zone (G). N, nucleus. Magnification, 6 000 x. 
(C) Mature megakaryocyte from the bone marrow of a p45 NF-E2 ~ mouse. Even at low magnification (2,500x), the lack of granules is apparent. 
(D) Detail of a megakaryocyte similar to the one shown in (C). The organization ofthe demarcation membrane system is aberrant, and granules 
(arrows) are small and sparse. Magnification, 6,000 x. 
megakaryocytes revealed a striking deficit in the number 
of granules and absence of platelet territories. Thus, 
thrombocytopenia results from a primary failure of platelet 
development rather than from a defect merely restricted 
to platelet release. 
The Defect in Maturation of p45 NF-E2 -/- 
Megakaryocytes Is Independent of the 
Action of Thrombopoietin 
Thrombopoietin/MGDF is believed to be the major physio- 
logical regulator of megakaryocyte proliferation and plate- 
let production, as serum levels correlate inversely with 
platelet counts in mice and rabbits (Kuter and Rosenberg, 
1994; Wendling et al., 1994). This implies positive and 
negative feedback regulation of thrombopoietin levels by 
platelet mass and predicts a greatly elevated level in p45 
NF-E2 -j- mice. To our surprise, serum thrombopoietin, de- 
termined with a sensitive in vitro bioassay that measures 
proliferation of a factor-dependent 32D cell line expressing 
mpl (Bartley et al., 1994), was not above the baseline level 
of littermate controls (data not shown). This unexpected 
result was verified independently by A. L. Gurney and F. J. 
de Sauvage (personal communication) with a similar assay 
(de Sauvage et al., 1994), and the possibility of inhibitors 
in the mutant serum accounting for the result was ex- 
cluded in mixing experiments (data not shown). 
This finding raised the possibility that the maturation 
defect of p45 NF-E2 -/- megakaryocytes reflects inade- 
quate thrombopoietin production or a failure to respond 
to the growth factor and led us to assess expression of 
the relevant genes in the mutant mice. mRNA transcripts 
for both mpl and thrombopoietin were present at compara- 
ble levels in fetal liver RNA samples from mutant and con- 
trol mice (Figure 7A). Thus, the expression of neither 
thrombopoietin or its receptor is dependent on NF-E2. 
To determine whether thrombocytopenia n p45 NF-E2 -/- 
mice results from the inability to respond to th rombopoietin 
signaling in vivo, recombinant human thrombopoietin was 
administered to mutant and control mice. Platelets re- 
mained undetectable in mice lacking p45 NF-E2, but in- 
creased appropriately in controls (Figure 7B); nonethe- 
less, the numbers of megakaryocytes in hematopoietic 
tissues were dramatically increased in both sets of mice 
(Figure 7C). These results demonstrate that the prolifera- 
tive response of megakaryocyte precursors to thrombo- 
poietin is intact in animals lacking p45 NF-E2 and indicate 
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Figure 7. Absolute Thrombocytopenia np45 NF-E2 -~- Mice Does Not 
Result from Absence of Mpl or Thrornbopoietin or from Failure to Re- 
spond to Thrombopoietin 
(A) RT-PCR analysis of mpl and thrombopoietin mRNAs from the fetal 
livers of mutant ( - / - )  mice and heterozygous (+/-) littermates. PCR 
reactions were carried out as in Figure 5. 
(B) Automated platelet counts incontrol (left, hatched bars) and mutant 
(right) mice before (-) and after (+) 7 days of administration of recombi- 
nant human thrombopoietin (TPO). Results represent the mean _+ 
SEM of measurements in seven control (+/+ or +/-) and four p45 
NF-E2 -~- adult mice. 
(C) Transverse sections of the spleen from control (Con; left) and p45 
NF-E2 -~- (Mut; right) adult mice treated with thrombopoietin as in (B), 
indicating a dramatic increase in the numbers of megakaryocytes in 
both cases. Magnification, 75 x.  
that the deficit leading to impaired megakaryocyte matura- 
tion is independent, of the actions of this growth factor. 
Discussion 
We have shown that absence of the hematopoietic- 
specific subunit (p45) of the bZlP transcription factor NF- 
E2 results in a complete, and apparently late, block in 
megakaryocyte maturation, such that circulating platelets 
are undetectable in vivo. Though dispensable for erythroid 
cell development, NF-E2 isthus obligatory for megakaryo- 
cyte maturation and thrombopoiesis. These unexpected 
findings have important implications f r megakaryocyte 
and platelet biology. 
NF-E2 in Megakaryocyte Differentiation 
and Gene Expression 
Our results demonstrate that lineage commitment and ini- 
tial phases of megakaryocyte development occur indepen- 
dent of the action of NF-E2. Proliferation in response to 
thrombopoietin, expression f selected lineage-specific 
markers (PF4, GPIIb, 4A5, and acetylcholinesterase), and 
endomitosis are unaffected in p45 NF-E2 -/- mice. Thus, 
in contrast with situations in which loss of transcription 
factors leads to ablation of one or more blood cell lineages 
at the level of an early precursor (see Orkin, 1995), loss 
of p45 NF-E2 interferes with megakaryocytic maturation 
at an advanced stage. The principal defect in p45 NF-E2 -/- 
megakaryocytes relates to cellular maturation: the ultra- 
structure reveals markedly reduced numbers of granules 
and failure to form platelet fields. While it~ isformally possi- 
ble that these effects result from absence of NF-E2 in a 
cell type other than the megakaryocyte (for example, a 
stromal or other hematopoietic cell), the normal expres- 
sion pattern of the p45 subunit, together with t e discrete 
intracellular defects observed within the mutant mega- 
karyocytes, suggests that the phenotype is cell auton- 
omous. 
Although late stages of nuclear maturation may overlap 
with early cytoplasmic events related to platelet formation, 
it is believed that endomitosis largely precedes the latter 
during megakaryocyte development (Odell and Jackson, 
1968; Paulus, 1970). Our observation of increased DNA 
ploidy in p46 NF-E2 -~- megakaryocytes is consistent with 
this model. Further, while effects of other cytokines cannot 
be excluded, the increased numbers, cell size, and DNA 
ploidy seen in the mutant megakaryocytes suggest an on- 
going response to endogenous thrombopoietin. The sig- 
nificance of other morphological changes, including em- 
peripolesis and nuclear hyperlobulation, is unclear; these 
may be caused directly by loss of NF-E2 function or related 
to secondary effects of thrombocytopenia or cell senes- 
cence. 
Our findings implicate NF-E2-regulated target genes as 
critical to megakaryocyte maturation and platelet forma- 
tion. Two nonmutually exclusive possibilities may be con- 
sidered. On the one hand, NF-E2 loss might influence a 
single target gene whose absence interrupts a cascade 
of essential events. For example, loss of a protein required 
for the formation of platelet granules might perturb subse- 
quent cellular maturation. Alternatively, NF-E2 might or- 
chestrate the expression of sets of genes that characterize 
the mature, platelet-producing megakaryocyte. Identifica- 
tion of genes controlled by NF-E2 in megakaryocytes will 
be necessary to address these possibilities. 
To date, the cis elements directing megakaryocyte- 
specific expression have b en defined for very few genes; 
in each instance, motifs recognized by proteins of the 
GATA and Ets families have been identified (Romeo t 
al., 1990; Ravid et al., 1992; Lemarchandel t al., 1993; 
Block et al., 1994). Functionally relevant NF-E2-binding 
sites have yet to be demonstrated in the promoter of any 
megakaryocyte-expressed gene. Use of subtractive hy- 
bridization or differential screening methods with RNA de- 
rived from normal and p45 NF-E2 -~- megakaryocytes 
should facilitate the search for NF-E2-regulated genes 
governing megakaryocyte maturation and thrombo- 
poiesis. 
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p45 NF-E2 -/- Mice: A Model for Absolute 
Thrombocytopenia 
Although thrombocytopenia has been described in mice 
with the scat mutation (Peters et al., 1990), in knockouts 
of the platelet-derived growth factor B (PDGF B) (Leveen 
et al., 1994), PDGF receptor (Soriano, 1994), and c-mpl 
(Gurney et al., 1994) genes, and in rare platelet storage 
pool diseases (Swank et al., 1993), the causes, magnitude 
of thrombocytopenia, nd clinical syndrome of each differ 
substantially from our observations in p45 NF-E2 -~- mice. 
Similarly, mice harboring a PF4 promoter-driven SV40 T 
transgene exhibit variable th rombocytopenia nd develop 
leukemia, but do not bleed excessively (Robinson et al., 
1994). Further, in three instances in which targeted disrup- 
tion of hematopoietic-specific transcription factor genes 
(Myb, PU.1, and GATA-1) results in severe erythroid or 
myelolymphoid efects in utero, megakaryocyte develop- 
ment is spared (Mucenski et al., 1991; Scott et al., 1994; 
Pevny et al., 1995). In contrast, mice lacking p45 NF-E2 
have a complete and sustained absence of circulating 
platelets. As such, they constitute a unique model in which 
to dissect molecular aspects of platetet development and 
regulation. For example, we have shown that serum levels 
of thrombopoietin may not depend exclusively on the ab- 
solute numbers of circulating platelets, as previously 
thought. Also, NF-E2 -~- mice may be useful in blastocyst 
complementation studies (Chen et al., 1993) to test the 
requirement for other genes in platelet development. 
There is no clear correspondence between the mega- 
karyocyte maturation abnormalities een in p45 NF-E2 -~- 
mice and known human platelet disorders. In humans, 
congenital thrombocytopenia is rare, and absolute throm- 
bocytopenia is probably lethal. Indeed, it is surprising that 
5%-10% of p45 NF-E2 -/- mice survive into adulthood. The 
hemostatic mechanisms operating in these survivors are 
presently unknown, but may include rare, circulating mega- 
karyocyte debris. 
NF-E2 Function in Megakaryocytes 
and Erythroid Cells 
The relatively mild erythrocyte abnormalities in p45 
NF-E2 -~- mice are surprising in light of prior studies impli- 
cating NF-E2 as a major enhancer protein for globin gene 
transcription (Ney et al., 1990b; Talbot and Grosveld, 
1991; R. A. S. et al., unpublished data). Nevertheless, 
the presence of abnormalities in two of the hematopoietic 
lineages in which NF-E2 is normally expressed indicates 
that the overlapping pattern of expression reflects func- 
tional requirements rather than a vestige of the shared 
lineage. We presume that the presence of compensating 
proteins in maturing erythrocytes accounts for their mild 
deficit and infer that similar proteins are either not ex- 
pressed or not functional in megakaryocytes. Although the 
differing effect on erythroid and megakaryocytic matura- 
tion raises the possibility that the p45 subunit of NF-E2 
forms heterodimers with distinct partners in each cell type, 
the similar appearance of gel-shift complexes formed on 
an NF-E2-binding site with nuclear extracts of erythroid 
and megakaryocytic ell lines (Romeo et al., 1990) sug- 
gests that this is not the case. As our findings argue that 
NF-E2 fulfills specific roles in megakaryocyte develop- 
ment, we speculate that the p45 NF-E2 protein evolved 
initially to function within a common progenitor and subse- 
quently developed distinct functions within the daughter 
lineages. 
NF-E2 and Thrombopoietin 
Animal models have supported the notion that the platelet 
count serves as the major physiological signal for thrombo- 
poietin production through positive as well as negative 
feedback (Kuter and Rosenberg, 1994; Wendling et al., 
1994). While this may yet be the case under physiological 
conditions, the normal serum thrombopoietin level seen 
in the face of profound thrombocytopenia n p45 NF-E2 -~- 
mice calls for an explanation. Our data are consistent with 
the hypothesis that the number of megakaryocytes pres- 
ent in hematopoietic tissues is an important physiological 
signal in the regulation of thrombopoietin production, as 
implied by previous experiments in rats and humans (Ma- 
zur et al., 1981; Miura et al., 1988). Alternately, other aspects 
of platelet function, which are deficient in p45 NF-E2 -~- 
mice, may be primary regulators of thrombopoietin pro- 
duction. Blood levels of the related growth factor erythro- 
poietin respond to a variety of signals, including hypoxia 
and metal ions (Goldberg et al., 1988), and the regulation 
of thrombopoietin production may be similarly complex. 
Indeed, megakaryocyte responses to varying platelet de- 
mands have been considered to be analogous to erythroid 
cell changes in response to low or high red cell counts 
(Burstein and Breton-Gorius, 1995). 
Biochemical correlates of individual phases of megakar- 
yocyte maturation and platelet production are poorly un- 
derstood. Nevertheless, thrombopoietin appears to exert 
substantial physiological effects on many aspects of mega- 
karyocyte maturation, including cell size, DNA ploidy, and 
platelet production (Bartley et al., 1994; de Sauvage et 
al., 1994; Kaushansky et al., 1994). These pleiotropic ef- 
fects are likely to be mediated by genes that are activated 
following a thrombopoietin-mediated signaling cascade. 
It is possible that a subset of genes responsive to this 
pathway are also regulated through NF-E2, particularly 
late in megakaryocyte development. Ifso, the identification 
of these target genes will converge on common molecular 
events that are critical for platelet formation. 
Future Prospects 
Targeted disruption of genes encoding lineage-restricted 
transcription factors often results in ablation of the lineage 
at a very early stage (reviewed by Orkin, 1995). Though 
useful in establishing factors as candidate regulators of 
cell fate decisions, such outcomes prohibit detailed analy- 
sis of presumptive target genes and of their roles in later 
stages of cell maturation. In contrast, the late develop- 
mental arrest seen in the absence of p45 NF-E2 provides 
a unique entry point into megakaryocyte development and 
thrombopoiesis. By virtue of a defined genetic defect, p45 
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NF-E2 -~- megakaryocytes  const i tute a powerfu l  resource  
for the systemat ic  analys is  o f  deve lopment  of  this l ineage, 
and the identi f icat ion of  NF-E2-regu lated genes  should  aid 
in def in ing the pathway by which plate lets  are produced 
within matur ing megakaryocytes .  
Experimental Procedures 
Targeted Disruption of the p45 NF-E2 Locus 
Murine p45 NF-E2 genomic sequences were isolated from a 129/Sv 
strain XFIXII library (Stratagene). A - 12 kb fragment extending from 
an EcoRV site in intron 1 to an artificial Notl site 5 kb 3' to the gene 
was subcloned, and a PGK-neo ~ cassette was introduced at the 
unique Sail site of exon 3. Transfected J1 ES cells (Li et al., 1992) 
were cultured and selected in G418 as before (Shivdasani et al., 1995). 
Genomic DNA was analyzed by Southern blotting (Figure 1B), using 
a 1 kb HindllI-EcoRV fragment as a flanking probe (Figure 1A). Blasto- 
cyst injections and animal husbandry were performed as described 
(Robertson, 1987). Male chimeras, identified by the agouti coat color, 
were mated with C57BL/6J (Jackson Laboratories) or 129/Sv (Taconic) 
females and heterozygous (p45 NF-E2 +/-) progeny identified by South- 
ern blot analysis of tail DNA. Heterozygote crosses generated homozy- 
gous (p45 NF-E2 -j-) mutant mice on either a mixed C57-129 or inbred 
129/Sv genetic background. 
Histological Analysis 
Following dissection, specimens were fixed overnight in 10% buffered 
formalin and embedded in paraffin. Sections (5-10 p.m) were stained 
with hematoxylin and eosin for histological examination. 
Hematological Analysis 
Peripheral blood cell counts were determined with a Technicon H3 
instrument. Blood (50 rd) was collected into microtiter EDTA tubes 
(Becton-Dickinson) and diluted 1:4 in preservation buffer (10 mM NaCI, 
150 mM KCI, 10 mM glucose, 1 mM MgCI2, 2.5 mM potassium phos- 
phate [pH 7.5]). Blood smears, prepared prior to dilution, were stained 
with Wright-Giemsa stain. 
Ultrastructural Studies 
Freshly excised spleens and bone marrow obtained from 15- to 17- 
week-old p45 NF-E2 -j and control mice were fixed in 3% glutaralde- 
hyde prior to routine processing for electron microscopy. Samples 
were postfixed in 2% osmium tetroxide, stained en boc with uranyl 
acetate, and dehydrated in graded ethanols prior to embedment in 
Polybed 812 (Polysciences, Incorporated). Embedded tissues were 
sectioned with an LKB Ultrotome Ill microtome, stained with uranyl 
acetate and lead citrate, and examined with a Siemens Elmiskop IA 
electron microscope. 
Detection of Gene Products 
Northern blot and immunoblot analyses were performed as described 
previously (Andrews et al., 1993a). For RT-PCR analysis, RNA was 
prepared from livers dissected from E15.5 fetuses (Chomczynski and 
Sacchi, 1987). First-strand cDNA synthesis and PCR reactions 
(94°Cx1', 60°Cxl ', 72°Cx2 ') in the presence of tracer [32P]dCTP were 
performed as described (Shivdasani et al., 1995). The number of PCR 
cycles corresponded to the high end of the range in which a linear 
increase in products could be detected. Reaction products were sepa- 
rated on nondenaturing 4% polyacrylamide gels. No reaction products 
were detected using RNA samples from which reverse transcriptase 
had been omitted (data not shown). Equivalence of mutant and control 
cDNA was verified using PCR reactions for actin and HPRT (data not 
shown). 
Primer Sets 
PF4, 5' CTC'I-I'GACATGAGCGTCGCTGCGG 3' and 5' CI-FGATCAC- 
CTCCAGGCAGGTGAA 3'; GPIIb, 5' AGGCAGAGAAGACTCCGGTA 
3' and 5q'ACCGAATATCCCCGGTAAC 3'; thrombopoietin, 5' CATA- 
CAGGGAGCCACI-ICAGT 3'and 5'AGACGCTCTG GGCCAGTGCCC 
3'; c-mpl, 5' CCCACCTGGGAGAAATGTGAAGAG 3' and 5' CCGGTG- 
TAGGTCTGGAAGCGAGGG 3'. Acetylcholinesterase activity was de- 
tected as described (Jackson, 1973). 
Measurement of Megakaryocyte DNA Content 
DNA distribution of megakaryocytes in unfractionated bone marrow 
was determined as previously described (Jackson et al., 1984). Marrow 
was harvested from the femurs of 6- to 12-week-old mutant and control 
mice and washed in CATCH medium (Levine and Fedorko, 1976). To 
label the megakaryocyte population, cell suspensions were incubated 
first with 4A5 monoclonal antibody supernatant (Burstein et al., 1992) 
and subsequently with fluorescein-conjugated goat anti-rat IgGF(ab')2 
(Tago, Incorporated); DNA was stained with propidium iodide in hypo- 
tonic citrate. Using a FACScan flow cytofluorometer (Becton-Dickin- 
son) and two-color flow cytometry, DNA content (2N to 64N) of all 
4A5-positive cells was measured. Only cells with DNA content ~>8N 
were considered, since the proportions of 2N and 4N platelet-antibody- 
stained cells in unfractionated marrow is highly dependent on selection 
of the green fluorescence gate. The proportion of cells in each ploidy 
class was determined by integrating the area under each peak. 
ThrombopoietinlMGDF Studies 
Serum levels were measured as described (Bartley et al., 1994), using 
mpl-transfected, th rombopoietin-dependent 32D cells. For in vivo stud- 
ies, purified recombinant full-length human factor (0.1 p.g/g body 
weight), prepared from transfected CHO cells (Amgen), was adminis- 
tered subcutaneously daily for 7 days prior to measurement of platelet 
counts or determination of megakaryocyte numbers. 
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